PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma

To compare PD-L1 expression between metastatic uveal melanoma (MUM) and metastatic cutaneous melanoma (MCM). A total of 295 MCM and 78 MUM specimens were analyzed for tumor cell PD-L1 expression. Additionally, 91 MCM and 45 MUM specimens were analyzed for PD-1 expression on tumor-infiltrating lympho...

Full description

Saved in:
Bibliographic Details
Published inImmunotherapy Vol. 9; no. 16; pp. 1323 - 1330
Main Authors Javed, Asad, Arguello, David, Johnston, Curtis, Gatalica, Zoran, Terai, Mizue, Weight, Ryan M, Orloff, Marlana, Mastrangelo, Michael J, Sato, Takami
Format Journal Article
LanguageEnglish
Published England Future Medicine Ltd 01.12.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To compare PD-L1 expression between metastatic uveal melanoma (MUM) and metastatic cutaneous melanoma (MCM). A total of 295 MCM and 78 MUM specimens were analyzed for tumor cell PD-L1 expression. Additionally, 91 MCM and 45 MUM specimens were analyzed for PD-1 expression on tumor-infiltrating lymphocytes. A total of 77/295 (26.1%) MCM specimens expressed PD-L1 as compared to 4/78 (5.1%) MUM specimens (p < 0.0001). PD-1 expression on tumor-infiltrating lymphocytes was greater in MCM (73.6%; 67/91) than in MUM (51.1%; 23/45), respectively (p = 0.009). Significant differences exist in PD-L1 expression between MCM and MUM. The lower PD-L1 expression in MUM may provide a rationale for failure of PD-1 inhibitor therapy and suggests that immune evasion in this disease may occur via alternative mechanisms.
ISSN:1750-743X
1750-7448
DOI:10.2217/imt-2017-0066